About
ADOR Diagnostics is a company focused on developing and manufacturing advanced in-vitro multiplex molecular diagnostic solutions. Their flagship product, the NATlab system, is a point-of-care molecular diagnostic platform designed for rapid and accurate diagnosis of infectious diseases and other medical conditions. The NATlab enables immediate syndromic testing, providing results within 30-45 minutes. Headquartered in Cyprus, ADOR Diagnostics has a strong research and operational presence in Israel, Italy, and Germany. The company serves small to mid-sized laboratories, doctor's offices, clinics, and various healthcare settings that require quick and reliable diagnostic solutions. The NATlab system features sample-to-answer automation, high multiplexing capability, and easy panel modification, making it adaptable to emerging pathogens. Its technology supports effective infectious disease management and pandemic response globally.
Technologies
Keywords
Company Information
-
Employees 11
-
Founded 2016
-
Total Funding $3500000
Location
7 Via Luigi Einaudi, Guidonia, Lazio, Italy, 00012